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Abstract
The cytoplasmic domains of viral glycoproteins influence the trafficking and subcellular localization of the glycoproteins and their
incorporation into virions. They also promote correct virus morphology and viral budding. The cytoplasmic domains of murine-leukemia-
virus envelope-protein TM subunits regulate membrane fusion. During virion maturation the carboxy-terminal 16 amino acid residues of
the TM protein are removed by the retroviral protease. Deletion of these residues activates envelope-protein-mediated membrane fusion. Our
quantitative analysis of the effects of Moloney murine leukemia virus TM mutations on envelope-protein function support the proposition
that a trimeric coiled coil in the TM cytoplasmic domain inhibits fusion. The data demonstrate that cleavage of the TM cytoplasmic domain
is not required for viral entry and provide evidence for a model in which fusogenic and nonfusogenic conformations of the envelope protein
exists in an equilibrium that is regulated by the cytoplasmic domain. In addition, a conserved tyrosine residue in the TM cytoplasmic domain
was shown to play an important role in envelope-protein incorporation into retroviral particles.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
Viral transmembrane glycoprotein complexes are re-
sponsible for the binding of enveloped viruses to cells and
the fusion of viral and cellular membranes that leads to viral
entry. Although the potential functions of the extravirion
domains are conceptually straightforward and have been
extensively explored, the roles of the membrane-spanning
and intravirion domains are less clear and have been less
thoroughly investigated. The membrane-spanning domains
may be playing sequence-specific roles in assembly, mem-
brane trafficking and localization, and membrane fusion.
The most commonly recognized functions of the intravirion
(cytoplasmic in the cell) domains are in glycoprotein traf-
ficking and subcellular localization (Grange et al., 2000;
Lodge et al., 1997; Raviprakash et al., 1990; Sauter et al.,
1996; Zhang et al., 2000) and incorporation into virions
(Christodoulopoulos and Cannon, 2001; Lindemann et al.,
1997; Owen and Kuhn, 1997; Owens and Rose, 1993;
Schnierle et al., 1997; Zhao et al., 1994). Roles in virion
morphology (Jin et al., 1997) and membrane-fusion com-
pletion and regulation have also been described (Bagai and
Lamb, 1996; Brody et al., 1994; Cathomen et al., 1998;
Gage et al., 1993; Januszeski et al., 1997; Kozerski et al.,
2000; Li et al., 2001; Mulligan et al., 1992; Ragheb and
Anderson, 1994; Rein et al., 1994; Ritter et al., 1993; Sergel
and Morrison, 1995). A role for the cytoplasmic domain of
certain retroviral envelope glycoproteins in the activation of
cell growth signaling pathways has also been suggested
(Beaufils et al., 1993; Palmarini et al., 2001). In most cases
the biochemical and structural bases for the mechanism of
action of the intravirion domain have escaped elucidation.
The envelope (Env) proteins of the murine leukemia
viruses (MuLVs), -retroviruses, provide an interesting
model system for investigating the role of viral glycoprotein
intravirion domains. During the progress of the Moloney
MuLV (Mo-MuLV) Env protein through the secretory sys-
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tem, it forms a trimer (Kamps et al., 1991). It is subse-
quently proteolytically processed into two subunits (Hen-
derson et al., 1984; Witte et al., 1977), gp70 (amino acids
34–468) and p15E (amino acids 470–665), that are linked
through a cystine bridge (Opstelten et al., 1998; Pinter et al.,
1997; Pinter et al., 1978; Sanders, 2000). The mature form
of Env is incorporated into a budding C-type retroviral
particle. The gp70 subunit (SU) is on the outside of the
virion, whereas the p15E protein (TM) possesses an extra-
virion domain, a membrane-spanning domain, and a 35-
amino-acid domain that resides within the virion (Pinter and
Honnen, 1983). The TM protein possesses at its amino-
terminus a sequence that encodes the fusion peptide, which,
upon exposure, promotes the first steps in the membrane-
fusion process that occurs during viral entry (Jones and
Risser, 1993; Taylor et al., 2001; Zhu et al., 1998). The
membrane-spanning domain of TM participates in the pro-
cess of membrane fusion in a sequence-dependent manner
(Taylor and Sanders, 1999). It has been proposed that the
binding of SU to the cellular receptor results in a thiol–
disulfide exchange reaction that eliminates the disulfide
bond between the SU and TM subunits. This reaction is
hypothesized to result in exposure of the TM fusion peptide
and, consequently, membrane fusion and viral entry (Pinter
et al., 1997; Sanders, 2000).
Mouse fibroblast NIH 3T3 cells are highly susceptible to
entry by Mo-MuLV and therefore bear the receptor to which
the Mo-MuLV Env binds. However, when NIH 3T3 cells
are mixed with cells expressing the Mo-MuLV Env protein,
no syncytia formation takes place. This appears to be a
paradoxical result, because cell–cell fusion is topologically
equivalent to viral envelope–cell membrane fusion, and
cells expressing a fusion protein are being mixed with cells
that possess cell surface receptors. Invoking a requirement
for endocytosis and low pH for the conformational changes
that lead to viral entry does not resolve the problem. Low-
ering the pH does not promote Mo-MuLV Env-mediated
cell–cell fusion as it does in the case of influenza hemag-
glutinin- or alpha-virus glycoprotein-mediated cell–cell fu-
sion. A possible resolution to the paradox resides in the
finding that during a late stage of virion maturation the
carboxy-terminal 16 amino-acid residues of the p15E pro-
tein are removed by the retroviral gag–pol-encoded pro-
tease. This modification produces the 12-kDa TM protein
(Crawford and Goff, 1985; Green et al., 1981; Henderson et
al., 1984; Katoh et al., 1985; Schultz and Rein, 1985; Shin-
nick et al., 1981; Sutcliffe et al., 1980). The Env protein
present on the membrane of an infected cell is therefore
structurally different from that found in a mature virion.
Removal of the carboxy-terminal region (the R peptide)
activates Env so that it is capable of fusing membranes in a
receptor-dependent fashion (Ragheb and Anderson, 1994;
Rein et al., 1994). Consequently, the Env is in a precursor
form in the infected cell and is processed to the mature,
membrane-fusion-competent form in the viral particle. Sim-
ilar data have recently been obtained concerning the enve-
lope proteins of spleen necrosis virus and porcine endoge-
nous retroviruses (Bobkova et al., 2002). A mutant Mo-
MuLV Env with an arginine residue substituting for
leucine-649 at the TM cytoplasmic domain cleavage site is
not proteolytically processed, and viral particles incorporat-
ing L649R Env have very low infectiousness (Rein et al.,
1994). However, there are some conflicting data. Cells ex-
pressing the envelope protein with the wild-type (full-
length) cytoplasmic domain can fuse with rat XC cells
(Januszeski et al., 1997; Jones and Risser, 1993). There are
conflicting data on the role of endocytosis in MuLV entry
(Katen et al., 2001; Lee et al., 1999; McClure et al., 1990;
Nussbaum et al., 1993; Ragheb and Anderson, 1994). Con-
tradictory data on the subcellular site of expression of the
Mo-MuLV Env also exist (Grange et al., 2000; Yu et al.,
1998). These data have important relevance for the deter-
mination of the site of assembly of Env and Mo-MuLV
cores. Finally, despite previous efforts, there is no under-
standing of the structural basis of the regulation of cell–cell
fusion by the TM cytoplasmic domain.
Through quantitative analysis of the effects of a variety
of modifications of the Mo-MuLV TM cytoplasmic domain
both within and without the context of the expression of
other viral components, we provide additional insight into
this complex phenomenon of fusion regulation. We also
propose a structural basis for the regulation of membrane
fusion by the TM cytoplasmic domain that unifies the avail-
able data.
Results
TM cytoplasmic truncation affects protein expression and
incorporation into virus particles
To investigate the structural basis of the regulation of
membrane fusion by the TM cytoplasmic domain (TMCD),
we examined the function of a panel of Mo-MuLV Envs
with various TMCD carboxy-terminal deletions (Fig. 1).
We expected that a direct comparison of their capacities
using our quantitative assays would offer insight into the
relative contributions of particular residues versus those of
the overall structure in fusion regulation. Expression and
processing of all mutant Envs with the exception of 653–
665 and 654–665 were at wild-type levels in gpGFP cells
(Fig. 2). The former had nearly normal levels of SU expres-
sion, but low levels of TM expression, whereas the 654–
665 had poor levels of expression of both SU and TM. It is
possible that the 653–665 TM is unstable. Nearly all of
the Envs exhibited dramatically reduced levels of incorpo-
ration into viral particles with the exceptions of the 639–
665 and 658–665 Envs. The R peptide is efficiently re-
moved in the recombinant virus particles in our expression
system, so the increase in migration of TM upon truncation
beyond the natural site of protease cleavage is readily evi-
dent.
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Quantitative measurement of syncytia formation and
transduction mediated by Envs bearing TMCD
truncations
Expression of the wild-type Mo-MuLV Env protein in
mouse NIH 3T3 cells, which bear the viral receptor and are
susceptible to entry by Mo-MuLV, does not lead to any
detectable syncytia formation. We investigated syncytia for-
mation promoted by expression of the various Mo-MuLV
Envs bearing TMCD deletions (Fig. 3). The level of syn-
cytia formation is likely to be a complex function of the
cell-surface concentration of the Env and of its inherent
capacity for fusion promotion. We found that removal of as
few as eight residues led to low but detectable syncytia
formation. It had previously been observed that deletion of
the carboxy-terminal seven residues of the Friend MuLV
TMCD, whose sequence is nearly identical to that of the
MoMuLV TMCD, did not promote syncytia formation
(Yang and Compans, 1997). Decreasing the length of the
TMCD increased syncytia formation until the TMCD length
was identical to that found in the mature TM intraparticle
domain. Further reductions in length progressively inhibited
cell–cell fusion.
Transduction by recombinant virus particles produced by
gpGFP cells expressing the mutant Mo-MuLV Envs was
measured (Fig. 4). Use of the 293T-derived cells, which
lack the receptor for Mo-MuLV, eliminates the distorting
effect upon quantification of transduction of producer-cell
syncytia formation that was present in earlier studies (Ja-
nuszeski et al., 1997). There is a decline in transduction as
the size of the carboxy-terminal deletion increases, although
when only eight residues remain (639–665), there is only
a fourfold reduction in transduction titer. There is not a
direct correlation between experimentally determined levels
of Env incorporation and transduction. These data indicate
that the TMCD is not playing an essential role beyond
membrane fusion and viral entry (Januszeski et al., 1997)
and that there is not a simple relationship between Env
incorporation levels and transduction. The TMCD does ap-
pear to modulate the efficiency of Env incorporation into
virus particles.
Fig. 1. Schematic of analyzed mutant Mo-MuLV Envs bearing mutations
in the TM cytoplasmic domain. The amino acid sequence of the Mo-MuLV
TM cytoplasmic domain beginning with isoleucine-631 is represented in
the one-letter code. The lengths of the cytoplasmic domains remaining in
the various deletion mutants are indicated by the solid bars above the
Mo-MuLV TMCD sequence. The dashed line represents the site of R-
peptide cleavage (between L649 and V650). The L649, L651, and Y655
point mutations are indicated below the Mo-MuLV TMCD sequence.
Fig. 2. Immunoblot analysis of cell lysate and virus bearing Mo-MuLV envelope proteins containing cytoplasmic domain truncations. Proteins in the
supernatant medium and cell lysate from gpGFP cells expressing the mutant envelope proteins were separated by SDS–PAGE and immunoblotted with
antibody against TM (A) and SU (B) as described under Materials and Methods. Analyses of cell lysate and virus from gpGFP cells that were transfected
with the plasmid encoding the wild-type envelope protein (w.t.) or that were mock transfected () are also presented. At left are indicated the positions of
TM (15 kDa) and SU (70 kDa).
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The sequence of the TMCD predicts formation of a
three-stranded coiled coil
The data with the Envs bearing the smaller TM trunca-
tions (650–665, 653–665, 654–665, and 658–665)
indicate that the inherent capacity of the Env for cell–cell
fusion promotion increases as the TMCD is shortened. This
is consistent with the concept that a structure in the cyto-
plasmic domain, whose effectiveness is determined by its
length, inhibits Env-mediated membrane fusion. The fact
that the 635–665 Env promotes syncytia formation, albeit
at a reduced level, indicates that the role of the TMCD is
predominantly to inhibit membrane fusion; there is not a
requirement, for example, for TMCD cleavage to occur so
that the remaining portion of the TMCD can interact in
some manner with the membrane.
Our analysis of the TMCD sequence suggests that it
inhibits fusion through formation of a trimeric coiled coil.
Coiled coils consist of interacting amphipathic  helices
whose amino acid sequences have a characteristic seven-
residue (heptad) repeat. Hydrophobic residues are generally
found at the a and d positions of the repeat. Our hypothetical
TMCD coiled coil has predominantly -branched aliphatic
residues at both the a and d interfacial positions (Fig. 5).
The -branched aliphatic residues at these positions have
been demonstrated to strongly favor the formation of three-
stranded coiled coils (Harbury et al., 1993). In addition, in
our predicted TMCD coiled coil a glutamine residue is
found at an a position, and, although glutamine residues are
rarely found at the a positions of dimeric coiled coils, they
are common at those positions in trimeric coiled coils
(Woolfson and Alber, 1995). Indeed, the replacement of the
conserved asparagine at the interface of the GCN4 dimeric
coiled coil with a glutamine residue favors trimeric coiled-
coil formation (Gonzalez et al., 1996). It is also noteworthy
that the leucine recognized by the viral protease at the
R-peptide cleavage site is not buried at the predicted mono-
mer–monomer interface.
Substitutions at the TMCD cleavage site produce effects
on cell–cell fusion and transduction
To further explore the roles of R peptide cleavage in
membrane-fusion regulation, we examined the effects of
substitutions at the R-peptide cleavage site on Env function
(Fig. 1). We altered leucine-649 to isoleucine and proline.
The viral protease that cleaves the R peptide generally
favors uncharged, not -branched residues at the P1 posi-
tion (L649 in the TMCD). We anticipated that each alter-
ation should inhibit processing by the viral protease and that
the Env bearing the L649P substitution should have an at
least partially disrupted coiled coil and should promote
Fig. 4. Functional particle formation by envelope proteins with cytoplasmic
domain truncations. The number of transducing units per milliliter of
medium collected from gpGFP cells transfected with plasmids encoding
Envs carrying carboxy-terminal truncations is plotted against the sequence
of the cytoplasmic domain (amino acids 631–665). Arrowheads indicate
the sites of truncation of the envelope proteins whose function is being
measured. The arrow indicates the site of envelope processing by the viral
protease.
Fig. 3. Variation of the efficiency of syncytia formation with envelope
protein cytoplasmic domain length. The number of nuclei per syncytium
(A) and the number of nuclei in syncytia (B) per 107 NIH 3T3 cells
transfected with plasmids encoding Envs carrying carboxy-terminal trun-
cations are plotted against the sequence of the cytoplasmic domain (amino
acids 631–665). Arrowheads indicate the sites of truncation of the enve-
lope proteins whose function is being measured. The arrow indicates the
site of envelope processing by the viral protease.
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syncytia formation in NIH 3T3 cells. We also made substi-
tutions at leucine-651 (L651I and L649I/L651I). The se-
quence surrounding L651 (648ALVLTQQY655) resembles
the cleavage site in the Gag–Pol polyprotein between the
Mo-MuLV protease and reverse transcriptase (LQVL/TLNI
(Copeland et al., 1985; Yoshinaka et al., 1985)), and we
were concerned that the alternative site might be utilized if
the primary site following L649 were eliminated.
Examination of the viral incorporation and processing of
the mutant envelope proteins produced by gpGFP cells
indicates that although the L651I is incorporated and pro-
cessed similarly to the wild-type, all the other Envs had
severe defects in TMCD processing (Fig. 6). The L649P
Env was very poorly incorporated into viral particles, and
the L649I/L651I Envs also had a major deficiency in incor-
poration. All of the mutant Envs were expressed at normal
levels in the cell (data not shown). It can be concluded that
the substitutions for L649 greatly inhibit if not eliminate
TMCD cleavage. It cannot be excluded that nevertheless,
for example, a small amount of cleavage of the L649I
TMCD occurs.
Measurements of the promotion of syncytia formation in
NIH 3T3 cells by the mutant Envs demonstrated that the
L649P Env mediated cell–cell fusion, whereas the other
Envs did not (Table 1). Cell–cell fusion with rat XC cells
does not require TMCD cleavage, although it is enhanced
by it. In an assay of fusion between 293T cells expressing
the mutant Envs and XC cells, the L649P Env was demon-
strated to possess syncytia-promotion capacities equivalent
to those of the 650–665 Env, whereas the L649I and
L651I Envs were three- to sixfold less potent in cell–cell
fusion than the wild-type bearing the full-length TMCD
(Table 1). The L649I/L651I Env was completely deficient
in syncytia formation.
Transduction by recombinant virus bearing the L649I
and L651I Envs was little affected, whereas the L649I/
L651I Env conveyed transduction at levels that were re-
duced threefold (Table 1). The lower levels of transduction
by virus bearing the L649P Env were consistent with the
Env incorporation data. It can be concluded that, under our
experimental conditions, TMCD cleavage is not required
for Mo-MuLV entry. In addition, although very low levels
of incorporation of mutant Envs into virus particles leads to
defects in viral transduction, it is clear that there is not a
Fig. 5. Helical-wheel representation of the heptad repeat of the Mo-MuLV
TM cytoplasmic domain. The seven structural positions of coiled-coil
heptad repeats are labeled a–g with positions a and d representing the
hydrophobic residues that form the helix interface. The helix begins with
residue L632 at position d and ends with residue K659 at position c. L649,
the site of protease cleavage, is indicated.
Fig. 6. Analysis of viral incorporation of mutant envelope proteins bearing
substitutions for the protease cleavage site. Virus particles produced by
gpGFP cells expressing the mutant envelope proteins were collected and
analyzed on a 10–20% gradient gel and probed with antibody against SU
(A) or TM (B). Analysis of virus particles budded from gpGFP cells
transfected with the plasmid encoding for the Mo-MuLV envelope protein
(w.t.) or mock transfected () are also presented. At left are indicated the
positions of SU (70 kDa), proTM (15 kDa), and TM (12 kDa). Because of
the distortion of the bands in the analysis on the left side of B, analysis of
virus particles containing the wild-type and L649I Envs was repeated. The
migration of the L649I TM clearly corresponds to that of the small amount
of unprocessed wild-type TM.
Table 1
Analysis of the ability of Mo-MuLV envelope proteins bearing
substitutions in the cytoplasmic domain to promote syncytia formation
and viral transduction
Mutant envelope
protein
Syncytia
formation
(NIH 3T3)a
Syncytia formation
(XC:293T)a
Virus titer
(TU/ml)b
L649I 0.25 9  2 7  2  104
L649P 5  1 95  8 6  2  103
L649I/L651I 0.25 0.4  0.6 3  2  104
L651I 0.25 5  2 1  0.2  105
Env 0.25 31  2 1  105
650–665 100 100 2  104
None 0.25 0.25 3
a The numbers represented here are normalized to the percentage nuclei
in syncytia of the wild-type envelope protein lacking the R peptide (650–
665), which is 15%.
b Virus titer is given as transducing units per milliliter (TU/ml).
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linear relationship between the levels of incorporation and
transduction.
Tyrosine-655 and Env incorporation
To explore further the roles of the TMCD and subcellular
localization signals in Env incorporation into virus particles
the conserved TMCD tyrosine (AA 655) was substituted
with alanine, phenylalanine, serine, or valine (Fig. 1). These
mutant Envs had previously been examined with respect to
targeting of Env expression and retroviral budding to the
basolateral membrane (Lodge et al., 1997). The Y655A,
Y655S, and Y655V Envs were completely defective in
basolateral targeting, whereas the Y655F Env was partially
deficient. Although expression of the Gag polyprotein pre-
cursor in transfected gpGFP cells (Fig. 7A) and of the CA
protein in virus particles (Fig. 7A) was uniform, and the
Envs bearing the substitutions for tyrosine-655 were ex-
pressed at the level of the wild-type Env (Fig. 7B), incor-
poration of the mutant Envs varied (Figs. 7B and C). The
Y655F Env was incorporated at the wild-type level, whereas
incorporation of the Y655A, Y655S, and Y655V Envs was
reduced. This was reflected in a modest reduction in titer by
virus particles bearing the Y655A, Y655S, and Y655V Envs
(Table 2).
Syncytia formation promoted by the mutant Envs was
also examined (Table 2). Although expression in NIH 3T3
cells of the Envs bearing substitutions for tyrosine-655 did
not lead to cell–cell fusion, expression of the Y655A,
Y655S, and Y655V Envs in 293T cells resulted in wild-type
levels of syncytia formation upon incubation with XC cells;
expression of the Y655F Env led to slightly reduced levels
of cell–cell fusion in this assay. It can be concluded that
expression of the Y655A, Y655S, and Y655V Envs at the
cell surface is unlikely to be greatly diminished compared to
that of the wild-type Env.
Discussion
A number of roles have previously been ascribed to the
cytoplasmic domains of viral glycoproteins. These include
regulation of the incorporation of viral glycoproteins into
virus particles, determination of the site and efficiency of
viral budding, governance of the conformation of the gly-
coprotein extracellular domain and processing, reduction of
cell-surface expression of the glycoprotein through promot-
ing endocytosis, and control of virus-particle morphology
and of virus envelope–cell membrane fusion (Bagai and
Lamb, 1996; Brody et al., 1994; Cathomen et al., 1998;
Christodoulopoulos and Cannon, 2001; Gage et al., 1993;
Grange et al., 2000; Jin et al., 1997; Kozerski et al., 2000;
Lodge et al., 1997; Mulligan et al., 1992; Ragheb and
Anderson, 1994; Raviprakash et al., 1990; Rein et al., 1994;
Ritter et al., 1993; Sauter et al., 1996; Schnierle et al., 1997;
Sergel and Morrison, 1995; Zhang et al., 2000; Zhao et al.,
1994).
We have made several major findings concerning the
Mo-MuLV TMCD. First, the length of the TMCD plays a
critical, if complex, role in the regulation of membrane
fusion and incorporation of Env into virus particles. The
data are consistent with the presence of a structure in the
cytoplasmic domain that inhibits and is not required for
fusion and whose disruption decreases Env incorporation.
We postulate that this structure is a three-stranded coiled
coil and provide some evidence in support of this hypoth-
esis. This model is consistent with the analysis of the effects
Fig. 7. Expression and viral incorporation of Envs bearing substitutions for
Y655. Immunoblot analysis of cell lysate and virus particles produced from
gpGFP cells expressing the mutant envelope proteins using antibody
against CA (A) or SU (B) was performed. Immunoblot analysis of the virus
particles using antibody against TM (C) was also performed. Virus and cell
lysate from cells transfected with the plasmid encoding the wild-type
envelope protein (w.t.) or mock transfected () were also analyzed. At left
are indicated the positions of the Gag polyprotein (65 kDa), CA (30 kDa),
SU (70 kDa), and TM (12 kDa).
Table 2
Analysis of the ability of Mo-MuLV envelope proteins bearing
substitutions in the cytoplasmic domain to promote syncytia formation
and viral transduction
Mutant envelope protein Viral titer
(TU/ml)a
Syncytia formation
(XC:293T)b
Y655A 5  1.0  104 28  2
Y655F 1  0.1  105 13  6
Y655S 4  0.6  104 35  7
Y655V 6  0.2  104 28  6
Env 1  105 25  6
650–665 2  104 100
None 3 3
a Virus titer is given as transducing units per milliliter (TU/ml).
b The numbers represented here are normalized to the percentage nuclei
in syncytia of the wild-type envelope protein lacking the R peptide (650–
665), which is 17%.
300 G.M. Taylor, D.A. Sanders / Virology 312 (2003) 295–305
of expression of other MuLV Envs bearing TMCD muta-
tions (Januszeski et al., 1997; Li et al., 2001; Yang and
Compans, 1997).
Second, detectable cleavage of the TMCD is not required
for viral entry. Elimination of the normal site of cleavage by
an isoleucine for leucine-649 substitution had little or no
effect on viral transduction (Table 1). These data are con-
sistent with those obtained previously that replication-com-
petent Mo-MuLV bearing the L649I substitution could be
produced, albeit with slower kinetics, after transfection of
mutant genomes into NIH 3T3 cells (Granowitz et al.,
1996). Elimination of both the major and a potential alter-
native cleavage site resulted in only a threefold reduction of
transduction.
Third, tyrosine-655, a residue that has been observed
previously to target Env expression and retroviral budding
to the basolateral membrane (Lodge et al., 1997) partici-
pates in enhancing the incorporation of the Mo-MuLV Env
into viral particles. Together these results have important
implications for the role of the TMCD in Env function.
Regulation of Env function by TMCD cleavage has the
hallmarks of the propagation of transmembrane conforma-
tional changes that occur during signal transduction. The
essential components of the fusion apparatus (the receptor-
binding domain, thiol–disulfide exchange motifs, and fu-
sion peptide) are on the extravirion side of the membrane.
The intact TMCD inhibits and is not required for mem-
brane-fusion activation. In this scenario, changes in the
conformation of the TMCD somehow alter the conforma-
tion of the extravirion region (Aguilar et al., 2003; Melikyan
et al., 2000). Such transmembrane conformational changes
are normally conceived as transpiring through the effects
that alterations in interactions between monomers on one
side of the membrane have upon intermonomer interactions
on the other side of the membrane. We have previously
proposed that a structure in the TMCD regulates the stabil-
ity of the oligomeric state of the envelope protein and
thereby its capacity for the promotion of membrane fusion
(Taylor and Sanders, 1999). We provide support for the
concept that it is a three-stranded coiled coil in the intact
TMCD that stabilizes the Env trimer. We suggest that there
is an equilibrium between a rigid Env trimer, in which
exposure of the fusion peptide upon receptor binding is
disfavored, and a looser trimer. In the Env with the intact
TMCD the rigid trimer is favored, whereas when the TMCD
is disrupted through cleavage, truncation, or mutation the
trimer is destabilized so that the fusion peptide can be
exposed upon receptor binding. This model is plausible in
the context of the structure of the mature influenza A virus
hemagglutinin in which the fusion peptide is buried at the
trimer interface. The postulation of this equilibrium also
provides a resolution to the seeming contradiction between
TMCD coiled-coil formation and the susceptibility of the
TMCD to R-peptide removal. Coiled coils exist in equilibria
with unfolded monomers (Zitzewitz et al., 1995) that would
be susceptible to cleavage. Our model implies that the
TMCD coiled coil is only of moderate stability. It should
also be noted that proteolytic processing of the TMCD is
inefficient and only has to occur once per trimer to desta-
bilize coiled-coil formation permanently.
Our hypothesis makes a number of predictions. The first
is that single substitutions in the cytoplasmic domain that
should disrupt the coiled coil may promote cell–cell fusion.
This prediction has been fulfilled with the L649P Env and
may underlie the activation of cell–cell fusion seen with
expression of some other mutant MuLV Envs. It has been
demonstrated recently that a single proline for alanine sub-
stitution in a predicted -helix in the cytoplasmic domain of
herpes simplex virus type-1 glycoprotein B also promotes
syncytia formation, as does deletion of the helix (Foster et
al., 2001). These data suggest that the regulation of mem-
brane fusion by viral glycoprotein cytoplasmic domains
may have common structural features.
It is noteworthy that the level of syncytia formation with
the L649P Env is not as high as that produced by the
650–665 Env upon expression in the NIH 3T3 cells,
although cell–cell fusion is at comparable levels for the two
Envs in the 293T/XC assay (Table 1). Soluble coiled coils
normally are at least 28 residues in length and are disrupted
by insertions of single proline residues. However, coiled
coils attached to membranes have one fewer degree of
freedom (they cannot rotate in a plane perpendicular to the
membrane) and therefore need not be as thermodynamically
stable as they would have to be if they were free in solution.
It has been shown with the influenza A virus hemagglutinin
that multiple insertions of proline residues may be required
for disruption of membrane-bound coiled coils (Qiao et al.,
1998).
Our hypothesis also predicts that there should exist Envs
bearing substitutions outside of the TMCD that should pro-
mote NIH 3T3 cell–cell fusion in the context of the full-
length wild-type TMCD. Mo-MuLV Envs bearing a substi-
tution of a serine residue for tryptophan-606 in the
juxtamembrane domain possess such a capacity (Taylor and
Sanders, 1999). The substitution may counteract the pres-
ence of the cytoplasmic domain by reducing trimer stability.
One alternative conjecture to the regulation of fusion-pep-
tide exposure by the TMCD is that the regulation of mem-
brane fusion occurs through alterations of the conformation
of the membrane-spanning domain, which itself may par-
ticipate in intermonomer interactions and directly in mem-
brane fusion (Taylor and Sanders, 1999).
The concept that the TMCD is regulating an equilibrium
between two forms of Env may explain the susceptibility of
XC cells to fusion even in the presence of a full-length TMCD
(Jones and Risser, 1993) and the lack of requirement for
TMCD cleavage in viral entry seen with the virus bearing the
L649I Env (Table I). XC cells may, for example, have active
receptors at higher local concentrations on its surface and,
given that there is an equilibrium between fusion-competent
and fusion-incompetent forms of Env, there may be sufficient
concentrations of active receptor–fusion complexes to lead to
some levels of fusion. In the case of the NIH 3T3 cells, there
may be insufficient concentrations of such complexes for fu-
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sion to occur. However, upon concentration of the Env in virus
particles there may be sufficient levels of receptor–Env com-
plexes for the unfavorable equilibrium to be overcome. It is
possible furthermore that cell–cell fusion is more sensitive to
subtle differences in protein processing or expression at the cell
surface than is transduction. This may explain the reduction in
fusion between 293T cells expressing the L649I and L651I
Envs and XC cells.
The data also provide information on the dependence of
Env incorporation upon the sequence of the TMCD that can be
explained most readily in the context of our structural model.
Retroviruses incorporate their glycoproteins preferentially over
cellular proteins. They can incorporate productively the glyco-
proteins of other enveloped viruses, but the structure of the
glycoprotein cytoplasmic domain appears to affect the effi-
ciency of incorporation (Christodoulopoulos and Cannon,
2001; Lindemann et al., 1997; Lodge et al., 1998; Schnierle et
al., 1997). An Mo-MuLV TMCD with an intact coiled coil
would have a compact structure that could be accommodated
in the virus particle. Once the Env is incorporated the rigidity
of the structure would be of lesser importance. As the TMCD
is truncated or as the putative TMCD coiled coil is disrupted
through mutation, the TMCD would become less compact and
therefore more difficult to incorporate into viral particles. At a
certain point, as exemplified by the 639–665 Env, the
TMCD is small enough to be incorporated despite the lack of
a stable coiled coil. This model can also explain data concern-
ing the incorporation of gibbon ape leukemia virus (GaLV)
and GaLV/MuLV chimeric Env incorporation into retroviral
and lentiviral particles (Christodoulopoulos and Cannon,
2001). The presence of a disordered structure in the TMCD
may also affect the stability of the mutant protein in the cell
(e.g., 654–665). These conclusions are not intended to rule
out the idea that there is in addition specific recognition of the
Mo-MuLV TMCD by the Mo-MuLV Gag polyprotein.
The results on viral incorporation obtained with the mu-
tant Envs bearing substitutions for tyrosine-655 may be
interpreted within the same structural context. In the pre-
dicted coiled coil, tyrosine-655 is on an exposed surface and
therefore available for recognition by cellular and/or viral
proteins. Tyrosine-655, which is present within a common
subcellular localization motif (YXX-hydrophobic) that in
other contexts promotes endocytosis (LaBranche et al.,
1995; Sauter et al., 1996), had previously been demon-
strated to target Env expression and retroviral budding to
the basolateral membrane (Lodge et al., 1997). If incorpo-
ration of Env into viral particles occurred at the plasma
membrane then one might have anticipated that removal of
a potential endocytosis signal would increase cell surface
expression of the Env and thereby increase the amount of
Env recovered in retroviral particles. In fact, although the
Y655A, Y655S, and Y655V Envs are expressed and pro-
cessed at wild-type levels and are capable of promoting
wild-type levels of syncytia formation between 293T and
XC cells, they are incorporated at greatly diminished levels.
The substitutions do not convert the Env into a form that is
fusogenic when expressed in NIH 3T3 cells, so the incor-
poration defect is not the result of the gross structural
alterations that we postulate occur when the TMCD coiled
coil is disrupted. These data also are evidence against the
hypothesis that the cell–cell fusion observed when the R
peptide is removed results from the elimination of the en-
docytosis signal in the TMCD (Grange et al., 2000).
Two alternatives concerning the role of tyrosine-655 are
possible. The first is that tyrosine-655 is directly involved in
contact with the Gag polyprotein and that phenylalanine can
at least partially substitute for the tyrosine residue. This is
similar to the postulated function of a conserved tyrosine
residue in the cytoplasmic domain of the alphavirus E2
glycoproteins (Zhao et al., 1994). In this model the Gag
polyprotein and the cellular sorting apparatus (e.g., the
proteins involved in endocytosis) compete for binding of
tyrosine-655. When the Gag polyprotein is not present in
high enough concentrations, the virus relies upon the cell to
remove the Env protein from the plasma membrane so that
immune recognition is inhibited. A similar model has been
suggested for the HIV-1 Env (Egan et al., 1996).
Another possibility is that, in the context of the full-
length TMCD, tyrosine-655 promotes the trafficking of Env
to a subcellular site, such as a lipid raft, where it can
promote retroviral budding (Pickl et al., 2001). Remarkably,
it has been demonstrated previously that the site of expres-
sion of the Mo-MuLV Env can dictate the site of budding of
HIV-1 in polarized epithelial cells, despite the lack of se-
quence similarity between the Mo-MuLV and HIV-1 TM-
CDs (Lodge et al., 1997). It was also determined that the
localization of budding produced by Env expression is de-
pendent upon tyrosine-655 (Lodge et al., 1997). It is not
implausible that tyrosine-655 directs the Env to a site where
its incorporation into Mo-MuLV particles takes place most
efficiently (Vincent et al., 1999), such as the endosomal
multivesicular bodies.
The sequence motif that contains tyrosine-655, Y-X-X-
aliphatic, is one that is recognized by certain SH2-domain-
containing proteins upon phosphorylation of the tyrosine by
tyrosine kinases. It has been proposed that such motifs in the
cytoplasmic domains of the bovine leukemia virus and Jaag-
siekte sheep retrovirus (JSRV) envelope proteins play roles
in the activation of cell-growth signaling pathways (Beaufils
et al., 1993; Palmarini et al., 2001). In the case of the JSRV
TMCD the tyrosine (tyr-590) that is critical for the ability of
the envelope protein to induce the cellular transformation
that is likely to lead to ovine pulmonary carcinoma is the
equivalent of the Mo-MuLV TM tyrosine-655. It appears
plausible that tyrosine-590 of JSRV Env also helps to dic-
tate the subcellular site of expression of Env.
Overall, the main purpose of the regulation of the pro-
cessing of the TMCD is to ensure that the Env is maximally
active only when it is present in the vehicle, the viral
particle, which guarantees the maximal transmission of the
viral genome concomitant with the fewest deleterious ef-
fects to the host. We propose that the Env protein exists in
an equilibrium between a form that is competent for fusion
promotion and one that is not competent and that it is the
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presence of a coiled coil in the TMCD that stabilizes the
fusion incompetent form. The existence of the equilibrium
allows for the promotion of membrane fusion by Envs
bearing intact TMCDs. We anticipate that secondary and
tertiary structures, as opposed to motifs, in the cytoplasmic
domains of other viral glycoproteins will be playing impor-
tant functional roles and that equilibria between conforma-
tional states will be recognized as critical regulators of
membrane fusion.
Materials and methods
Cell lines and cell culture
Mouse NIH 3T3 fibroblast cells were grown in Dulbec-
co’s modified Eagle’s medium (DMEM; Sigma) with 10%
calf serum (CS; Sigma), penicillin (10 U/ml), and strepto-
mycin (0.1 mg/ml) (PS; Sigma) (DMEM CS/PS). 293T and
gpGFP cells (which produce envelope protein-deficient rep-
lication-incompetent Mo-MuLV particles carrying MFG.S
GFP-S65T, a retroviral vector encoding the Aequorea vic-
toria green fluorescent protein S65T mutant (Taylor and
Sanders, 1999), were grown in DMEM with 10% fetal
bovine serum (FBS; Sigma) and PS. Rat XC sarcoma cells
were grown in modified Eagle’s medium (MEM; Sigma)
with 10% FBS and PS.
Construction of plasmids encoding Mo-MuLV envelope
proteins bearing substitutions in the cytoplasmic domain
For the 653–665, 654–665, 656–665, 658–665,
L649I, and L649P mutations in the cytoplasmic domain, the
penv1650–665 plasmid (Taylor and Sanders, 1999) was
cut with StuI and NheI and ligated with double-stranded
oligonucleotides encoding the mutations. The 635–665,
639–665, and 642–665 mutations were constructed by
ligating the doubled-stranded oligonucleotides encoding the
mutations between the ClaI and NheI site in the penv
1650–665 plasmid. Plasmids encoding the substitutions
for tyr-655 (alanine, phenylalanine, serine, or valine) have
been used previously (Lodge et al., 1997) and contain dou-
ble-stranded oligonucleotides encoding for the mutations
inserted between the StuI and AflII sites of penv1min (Tay-
lor and Sanders, 1999).
Syncytia formation assays
Syncytia formation assays using NIH 3T3 cells were
carried out as described previously (Taylor and Sanders,
1999). NIH 3T3 cells (5105) were transiently transfected
with 4 g of mutant Env-encoding plasmids using Lipo-
fectAMINE (Gibco, BRL) and Opti-MEM media (Gibco
BRL). Syncytia and the number of nuclei in syncytia were
counted 32 h posttransfection. There were approximately
1200 cells per field. Syncytia assays were carried out in
triplicate.
When syncytia formation promotion by Mo-MuLV en-
velope proteins containing the full-length cytoplasmic tail
expressed in 293T cells was examined, 2  106 293T cells
were transfected with 4 g DNA using LipofectAMINE as
above. Twenty four hours posttransfection XC cells and
293T cells were trypsinized and mixed by plating 2  106
293T cells and 1  106 XC cells on a 60-mm tissue culture
dish. After 24 h of growth in DMEM with 10% FBS and PS
the syncytia were counted.
Viral transduction assay
Transduction assays were carried out as described pre-
viously (Taylor and Sanders, 1999). Plasmids encoding the
mutant envelope proteins were transiently transfected into
gpGFP cells (Taylor and Sanders, 1999). Medium from the
transiently transfected gpGFP cells was incubated with
1106 NIH 3T3 cells in the presence of 8 g/ml hexad-
imethrine bromide for 4 h. Forty-eight hours later the cells
were removed from the plate and analyzed by flow cytom-
etry with a Coulter XL-MCL flow cytometer, using a
525-nm bandpass filter and a 488-nm air cooled argon laser.
Transduction assays were carried out in triplicate.
SDS–PAGE and immunoblot analysis
Virus produced by transfected gpGFP cells was filtered
and pelleted through a 25% sucrose cushion at 75,000g and
4°C for 2.5 h in a 50.2 Ti Beckman rotor and suspended in
equal volumes of 1  RIPA (140 mM NaCl, 10 mM
Tris–HCl; pH 8.0, 5mM EDTA, 1% Na deoxycholate, 1%
Triton X-100, and 0.1% SDS) buffer and SDS–PAGE sam-
ple buffer with -mercaptoethanol. The cells were washed
twice with phosphate-buffered saline and lysed in 1 ml of
lysis buffer (50 mM Tris–HCl; pH 8.0, 5 mM EDTA, 150
mM NaCl, and 1% Triton X-100). The cell debris was
removed by centrifugation at 16,000g. A 15-l aliquot was
used for immunoblot analysis. When antibody against SU
was used, the protein samples were run on 7% SDS–PAGE
gels, transferred to nitrocellulose as described previously
(Sharkey et al., 2001), and probed with goat anti-Rauscher
leukemia virus (RLV) gp70 antiserum (lot 80S-019; Quality
Biotech) (1:1000) and rabbit anti-goat conjugated to horse-
radish peroxidase (Chemicon) (1:2500). Proteins were de-
tected by using the ECL detection system (Amersham).
When antibody against TM was used, the protein samples
were run on 10–20% gradient gels, transferred to PVDF
membrane (Millipore) at 100 mA for 1 h in transfer buffer
and probed with 2 g/ml rat monoclonal antibody
10CE11(kindly provided by A. Pinter (Li et al., 1997)) and
goat anti-rat conjugated to horseradish peroxidase (Chemi-
con) (1:10,000). Proteins were detected by using the Pierce
Supersignal detection system (Pierce). When antibody
against capsid protein was used, membranes were probed
using goat anti-RLV p30 antiserum (lot 78S000221; Quality
Biotech) (1:1000) and rabbit anti-goat conjugated to horse-
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radish peroxidase (Chemicon) (1:2500). Proteins were de-
tected by using the ECL detection system (Amersham).
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